Last 12 months
Inside the activity.
1 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2023 Filed Jun 6, 2023 23:41 UTC |
Meisner LaraChief Legal Officer
|
Exercise / conversionCommon Stock | 1,875 | $14.00 | $26,250.00 |
DisclosureSEC source: 0000899243-23-014615 · doc4.xml · nonDerivative · entry 1 Meisner Lara · CIK 0001883986 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 12, 2023 Filed Apr 12, 2023 23:05 UTC |
Myers Scott DunsethDirector · Chief Executive Officer
|
PurchaseCommon Stock | 4,000 | $25.37 | $101,478.80 |
DisclosureSEC source: 0000950170-23-012595 · ownership.xml · nonDerivative · entry 1 Myers Scott Dunseth · CIK 0001356256 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,500 Read SEC document |
| March 13, 2023 Filed Mar 13, 2023 20:06 UTC |
Myers Scott DunsethDirector · Chief Executive Officer
|
PurchaseCommon Stock | 5,500 | $29.15 | $160,324.45 |
DisclosureSEC source: 0000950170-23-007570 · ownership.xml · nonDerivative · entry 1 Myers Scott Dunseth · CIK 0001356256 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,500 Read SEC document |
| March 09, 2023 Filed Mar 10, 2023 21:05 UTC |
Meisner LaraGeneral Counsel and Secretary
|
SaleCommon Stock | 29,971 | $29.07 | $871,256.97 |
DisclosureSEC source: 0000899243-23-007996 · doc4.xml · nonDerivative · entry 1 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.23 to $29.81. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.23 to $29.81. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 21:47 UTC |
Meisner LaraGeneral Counsel and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 108,000 | $0.00 Strike: $34.20 | $0.00 |
DisclosureSEC source: 0000899243-23-004588 · doc4.xml · derivative · entry 1 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,000 Underlying: Common Stock · 108,000 shares Expires 2033-02-08 F1 · derivative.exercise_date: The option vests in equal monthly installments through February 8, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 16:51 UTC | GrantStock Option (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $34.20 | $0.00 |
DisclosureSEC source: 0000899243-23-004593 · doc4.xml · derivative · entry 1 Melvin Carrie · CIK 0001935199 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2033-02-08 F1 · derivative.exercise_date: The option vests in equal monthly installments through February 8, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
|
| February 08, 2023 Filed Feb 10, 2023 16:49 UTC |
Humer KristianCFO and CBO
|
GrantStock Option (Right to Buy) · Derivative | 108,000 | $0.00 Strike: $34.20 | $0.00 |
DisclosureSEC source: 0000899243-23-004592 · doc4.xml · derivative · entry 1 Humer Kristian · CIK 0001872280 · CFO and CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,000 Underlying: Common Stock · 108,000 shares Expires 2033-02-08 F1 · derivative.exercise_date: The option vests in equal monthly installments through February 8, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 21:54 UTC |
Katz BarrettChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 108,000 | $0.00 Strike: $34.20 | $0.00 |
DisclosureSEC source: 0000899243-23-004595 · doc4.xml · derivative · entry 1 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,000 Underlying: Common Stock · 108,000 shares Expires 2033-02-08 F1 · derivative.exercise_date: The option vests in equal monthly installments through February 8, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 23:55 UTC |
Myers Scott DunsethDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 1,000,000 | $0.00 Strike: $35.80 | $0.00 |
DisclosureSEC source: 0000899243-23-004238 · doc4.xml · derivative · entry 2 Myers Scott Dunseth · CIK 0001356256 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2033-02-06 F2 · derivative.exercise_date: The option vests 25% on February 6, 2024 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 23:55 UTC |
Myers Scott DunsethDirector · Chief Executive Officer
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004238 · doc4.xml · nonDerivative · entry 1 Myers Scott Dunseth · CIK 0001356256 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 F1 · kind: Represents restricted stock units that vest 25% on February 6, 2024 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 23:12 UTC |
Violin JonathanDirector · Chief Executive Officer
|
SaleCommon Stock | 50,000 | $36.80 | $1,840,000.00 |
DisclosureSEC source: 0000899243-23-003921 · doc4.xml · nonDerivative · entry 1 Violin Jonathan · CIK 0001730615 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,905 F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $36.1523 to $37.3689. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 02, 2023 Filed Feb 7, 2023 23:35 UTC Amendment |
Violin JonathanDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.15 | $0.00 |
DisclosureSEC source: 0000899243-23-004233 · doc4a.xml · derivative · entry 3 Violin Jonathan · CIK 0001730615 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,205 Underlying: Common Stock · 50,000 shares Expires 2030-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 25% on September 23, 2021 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| February 02, 2023 Filed Feb 7, 2023 23:35 UTC Amendment |
Violin JonathanDirector · Chief Executive Officer
|
SaleCommon Stock | 50,000 | $36.80 | $1,840,000.00 |
DisclosureSEC source: 0000899243-23-004233 · doc4a.xml · nonDerivative · entry 2 Violin Jonathan · CIK 0001730615 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,905 F2 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $36.1523 to $37.3689. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 02, 2023 Filed Feb 7, 2023 23:35 UTC Amendment |
Violin JonathanDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 50,000 | $0.15 | $7,500.00 |
DisclosureSEC source: 0000899243-23-004233 · doc4a.xml · nonDerivative · entry 1 Violin Jonathan · CIK 0001730615 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Due to a broker error, the Form 4 filed by the Reporting Person on February 3, 2023 incorrectly reported the source of shares sold on February 2, 2023 pursuant to the Reporting Person's Rule 10b5-1 trading plan. This amendment reflects the exercise of stock options for 50,000 shares of common stock, which were the source of the shares sold. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 23:04 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,872 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002674 · doc4.xml · derivative · entry 5 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,003 Underlying: Common Stock · 1,872 shares Expires 2031-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 25% on September 22, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 23:04 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,971 | $0.00 Strike: $23.03 | $0.00 |
DisclosureSEC source: 0000899243-23-002674 · doc4.xml · derivative · entry 4 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,750 Underlying: Common Stock · 4,971 shares Expires 2031-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested 25% on December 2, 2021 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 23:04 UTC |
Meisner LaraGeneral Counsel and Secretary
|
SaleCommon Stock | 6,843 | $35.66 | $244,021.38 |
DisclosureSEC source: 0000899243-23-002674 · doc4.xml · nonDerivative · entry 3 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $35.22 to $36.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $35.22 to $36.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 23:04 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 1,872 | $14.00 | $26,208.00 |
DisclosureSEC source: 0000899243-23-002674 · doc4.xml · nonDerivative · entry 2 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 23:04 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 4,971 | $23.03 | $114,482.13 |
DisclosureSEC source: 0000899243-23-002674 · doc4.xml · nonDerivative · entry 1 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC |
Katz BarrettChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 24,853 | $0.00 Strike: $23.03 | $0.00 |
DisclosureSEC source: 0000899243-23-002075 · doc4.xml · derivative · entry 6 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,000 Underlying: Common Stock · 24,853 shares Expires 2031-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC |
Katz BarrettChief Medical Officer
|
SaleCommon Stock | 24,853 | $37.21 | $924,780.13 |
DisclosureSEC source: 0000899243-23-002075 · doc4.xml · nonDerivative · entry 4 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $37.00 to $37.58. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC |
Katz BarrettChief Medical Officer
|
Exercise / conversionCommon Stock | 24,853 | $23.03 | $572,364.59 |
DisclosureSEC source: 0000899243-23-002075 · doc4.xml · nonDerivative · entry 3 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,853 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 22:58 UTC |
Katz BarrettChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,147 | $0.00 Strike: $23.03 | $0.00 |
DisclosureSEC source: 0000899243-23-002075 · doc4.xml · derivative · entry 5 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,853 Underlying: Common Stock · 4,147 shares Expires 2031-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 22:58 UTC |
Katz BarrettChief Medical Officer
|
SaleCommon Stock | 4,147 | $37.01 | $153,480.47 |
DisclosureSEC source: 0000899243-23-002075 · doc4.xml · nonDerivative · entry 2 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $37.00 to $37.05. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 22:58 UTC |
Katz BarrettChief Medical Officer
|
Exercise / conversionCommon Stock | 4,147 | $23.03 | $95,505.41 |
DisclosureSEC source: 0000899243-23-002075 · doc4.xml · nonDerivative · entry 1 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 00:09 UTC |
Katz BarrettChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 47,377 | $0.00 Strike: $23.03 | $0.00 |
DisclosureSEC source: 0000899243-23-001626 · doc4.xml · derivative · entry 6 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,000 Underlying: Common Stock · 47,377 shares Expires 2031-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 00:09 UTC |
Katz BarrettChief Medical Officer
|
SaleCommon Stock | 47,377 | $35.30 | $1,672,408.10 |
DisclosureSEC source: 0000899243-23-001626 · doc4.xml · nonDerivative · entry 4 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $33.76 to $35.934. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 00:09 UTC |
Katz BarrettChief Medical Officer
|
Exercise / conversionCommon Stock | 47,377 | $23.03 | $1,091,092.31 |
DisclosureSEC source: 0000899243-23-001626 · doc4.xml · nonDerivative · entry 3 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2023 Filed Jan 12, 2023 00:09 UTC |
Katz BarrettChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,623 | $0.00 Strike: $23.03 | $0.00 |
DisclosureSEC source: 0000899243-23-001626 · doc4.xml · derivative · entry 5 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,377 Underlying: Common Stock · 12,623 shares Expires 2031-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| January 09, 2023 Filed Jan 12, 2023 00:09 UTC |
Katz BarrettChief Medical Officer
|
SaleCommon Stock | 12,623 | $33.04 | $417,063.92 |
DisclosureSEC source: 0000899243-23-001626 · doc4.xml · nonDerivative · entry 2 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $33.00 to $33.135. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 09, 2023 Filed Jan 12, 2023 00:09 UTC |
Katz BarrettChief Medical Officer
|
Exercise / conversionCommon Stock | 12,623 | $23.03 | $290,707.69 |
DisclosureSEC source: 0000899243-23-001626 · doc4.xml · nonDerivative · entry 1 Katz Barrett · CIK 0001841628 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2022 Filed Dec 22, 2022 21:42 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,326 | $0.00 Strike: $23.03 | $0.00 |
DisclosureSEC source: 0000899243-22-039217 · doc4.xml · derivative · entry 6 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,721 Underlying: Common Stock · 16,326 shares Expires 2031-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 25% on December 2, 2021 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| December 21, 2022 Filed Dec 22, 2022 21:42 UTC |
Meisner LaraGeneral Counsel and Secretary
|
SaleCommon Stock | 16,326 | $29.19 | $476,555.94 |
DisclosureSEC source: 0000899243-22-039217 · doc4.xml · nonDerivative · entry 4 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.01 to $29.5665. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.01 to $29.5665. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 21, 2022 Filed Dec 22, 2022 21:42 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 16,326 | $23.03 | $375,987.78 |
DisclosureSEC source: 0000899243-22-039217 · doc4.xml · nonDerivative · entry 3 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 21:42 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 600 | $0.00 Strike: $23.03 | $0.00 |
DisclosureSEC source: 0000899243-22-039217 · doc4.xml · derivative · entry 5 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,047 Underlying: Common Stock · 600 shares Expires 2031-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 25% on December 2, 2021 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 21:42 UTC |
Meisner LaraGeneral Counsel and Secretary
|
SaleCommon Stock | 600 | $28.07 | $16,842.00 |
DisclosureSEC source: 0000899243-22-039217 · doc4.xml · nonDerivative · entry 2 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.03 to $28.09. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.03 to $28.09. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 21:42 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 600 | $23.03 | $13,818.00 |
DisclosureSEC source: 0000899243-22-039217 · doc4.xml · nonDerivative · entry 1 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 00:22 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,297 | $0.00 Strike: $23.03 | $0.00 |
DisclosureSEC source: 0000899243-22-039056 · doc4.xml · derivative · entry 6 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,647 Underlying: Common Stock · 1,297 shares Expires 2031-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 25% on December 2, 2021 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 00:22 UTC |
Meisner LaraGeneral Counsel and Secretary
|
SaleCommon Stock | 1,297 | $28.44 | $36,886.68 |
DisclosureSEC source: 0000899243-22-039056 · doc4.xml · nonDerivative · entry 4 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.00 to $28.72. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.00 to $28.72. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 00:22 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 1,297 | $23.03 | $29,869.91 |
DisclosureSEC source: 0000899243-22-039056 · doc4.xml · nonDerivative · entry 3 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 00:22 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $23.03 | $0.00 |
DisclosureSEC source: 0000899243-22-039056 · doc4.xml · derivative · entry 5 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,944 Underlying: Common Stock · 300 shares Expires 2031-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 25% on December 2, 2021 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 00:22 UTC |
Meisner LaraGeneral Counsel and Secretary
|
SaleCommon Stock | 300 | $28.08 | $8,424.00 |
DisclosureSEC source: 0000899243-22-039056 · doc4.xml · nonDerivative · entry 2 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.00 to $28.115. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.00 to $28.115. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 00:22 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 300 | $23.03 | $6,909.00 |
DisclosureSEC source: 0000899243-22-039056 · doc4.xml · nonDerivative · entry 1 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 01:56 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,656 | $0.00 Strike: $23.03 | $0.00 |
DisclosureSEC source: 0000899243-22-038520 · doc4.xml · derivative · entry 6 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,244 Underlying: Common Stock · 15,656 shares Expires 2031-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 25% on December 2, 2021 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 01:56 UTC |
Meisner LaraGeneral Counsel and Secretary
|
SaleCommon Stock | 15,656 | $28.12 | $440,246.72 |
DisclosureSEC source: 0000899243-22-038520 · doc4.xml · nonDerivative · entry 4 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.00 to $28.33. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.00 to $28.33. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 01:56 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 15,656 | $23.03 | $360,557.68 |
DisclosureSEC source: 0000899243-22-038520 · doc4.xml · nonDerivative · entry 3 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 01:56 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 600 | $0.00 Strike: $23.03 | $0.00 |
DisclosureSEC source: 0000899243-22-038520 · doc4.xml · derivative · entry 5 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,900 Underlying: Common Stock · 600 shares Expires 2031-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 25% on December 2, 2021 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 01:56 UTC |
Meisner LaraGeneral Counsel and Secretary
|
SaleCommon Stock | 600 | $28.05 | $16,830.00 |
DisclosureSEC source: 0000899243-22-038520 · doc4.xml · nonDerivative · entry 2 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.02 to $28.115. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.02 to $28.115. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 01:56 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 600 | $23.03 | $13,818.00 |
DisclosureSEC source: 0000899243-22-038520 · doc4.xml · nonDerivative · entry 1 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 23:45 UTC |
Meisner LaraGeneral Counsel and Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,125 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0000899243-22-036044 · doc4.xml · derivative · entry 3 Meisner Lara · CIK 0001883986 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,875 Underlying: Common Stock · 8,125 shares Expires 2031-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested 25% on September 22, 2022 and the remainder vests in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.